|
26
|
Monashee Investment Management
Boston,
Massachusetts
|
$5.6M
|
-$510K
|
-36,054
|
-13%
|
|
|
27
|
Sofinnova Investments
Menlo Park,
California
|
$5.43M
|
-$5.49M
|
-388,161
|
-63%
|
|
|
28
|
|
$5.28M
|
+$1.64M
|
+115,993
|
+108%
|
|
|
29
|
Paradigm Biocapital Advisors
New York
|
$5.04M
|
+$3.01M
|
+212,961
|
New
|
|
|
30
|
Nuveen
Charlotte,
North Carolina
|
$4.97M
|
-$1.25M
|
-88,314
|
-23%
|
|
|
31
|
|
$4.74M
|
-$35.2K
|
-2,487
|
-1%
|
|
|
32
|
Acuta Capital Partners
Redwood City,
California
|
$4.73M
|
–
|
–
|
–
|
|
|
33
|
Lord, Abbett & Co
Jersey City,
New Jersey
|
$4.46M
|
+$48.4K
|
+3,417
|
+2%
|
|
|
34
|
Parkman Healthcare Partners
Stamford,
Connecticut
|
$3.89M
|
-$1.21M
|
-85,653
|
-34%
|
|
|
35
|
Opaleye Management
Boston,
Massachusetts
|
$3.22M
|
+$1.92M
|
+136,000
|
New
|
|
|
36
|
Fiduciary Trust
Boston,
Massachusetts
|
$3.13M
|
–
|
–
|
–
|
|
|
37
|
|
$2.76M
|
+$1.65M
|
+116,622
|
New
|
|
|
38
|
Citadel Advisors
Miami,
Florida
|
$2.65M
|
-$832K
|
-58,758
|
-34%
|
|
|
39
|
Bank of New York Mellon
New York
|
$2.38M
|
-$439
|
-31
|
-0%
|
|
|
40
|
|
$2.06M
|
+$1.23M
|
+87,100
|
New
|
|
|
41
|
Two Sigma Advisers
New York
|
$2.02M
|
-$4.16M
|
-293,600
|
-77%
|
|
|
42
|
Tekla Capital Management
Boston,
Massachusetts
|
$1.83M
|
–
|
–
|
–
|
|
|
43
|
Charles Schwab
San Francisco,
California
|
$1.71M
|
+$24.4K
|
+1,724
|
+2%
|
|
|
44
|
Cinctive Capital Management
New York
|
$1.56M
|
+$425K
|
+30,000
|
+83%
|
|
|
45
|
Swiss National Bank
Zurich,
Switzerland
|
$1.48M
|
+$87.8K
|
+6,200
|
+11%
|
|
|
46
|
Fred Alger Management
New York
|
$1.16M
|
+$692K
|
+48,921
|
New
|
|
|
47
|
Schonfeld Strategic Advisors
New York
|
$936K
|
+$58K
|
+4,100
|
+12%
|
|
|
48
|
International Biotechnology Trust
London,
United Kingdom
|
$833K
|
+$308K
|
+21,741
|
+36%
|
|
|
49
|
Country Trust Bank
Bloomington,
Illinois
|
$832K
|
–
|
–
|
–
|
|
|
50
|
State of Wisconsin Investment Board
Madison,
Wisconsin
|
$825K
|
-$317K
|
-22,400
|
-39%
|
|
